Introduction

The SRSLY NGS Library Prep Kit from ClaretBio offers an efficient and simplified solution for library preparation using a technology based on single-stranded DNA through a ligation method. Unlike traditional library preparations, which are based on double-stranded DNA, SRSLY kits allow the entire DNA of the initial sample to be transformed into a sequenceable library, even in samples with minimal amounts of DNA (250 pg) and degraded DNA (kits compatible with paraffin-extracted DNA, ancient DNA…). Additionally, this kit enables the generation of complex libraries in a very short time of ~2.5 hours.

Detailed Description

The SRSLY kit provides three bead purification options (retention of small, moderate, and large fragments), adapting to different types and sizes of starting DNA. Available in a modular format, it offers maximum flexibility for the user in the choice of base kit, reaction volume, bead purification, and the addition of unique molecular indices (UMI) or dual indices (UDI) during PCR amplification.

imagen 2024 07 17 125430394

Key Aspects

  • Fast and efficient: Preparation in 2.5 hours.
  • Versatility: Suitable for low starting amounts of DNA (such as cfDNA) and degraded DNA (ancient DNA, paraffin-extracted DNA).
  • Modularity: Allows customization according to project needs.
  • Bead purification: Three options for different fragment sizes.
  • UMI and UDI primers: For precise identification and reduction of PCR duplicates.
imagen 2024 07 17 125338135
imagen 2024 07 17 125147836

What the Kit includes

  • Base kit for 24 or 96 reactions.
  • UMI and UDI primer options.
  • Bead purification modules.
  • Detailed user manual and technical support.

Area:

Forensic Genetics, Solid tumor

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Next Generation Sequencing (NGS)

Homologous Recombination Solutions (HRS)

Portfolio of hybrid capture-based NGS solutions for the analysis of genes involved in homologous recombination repair (HRR) and the study of alterations associated with the homologous recombination pathway in different types of cancer. The range includes three scalable panels designed to meet different analytical needs: mini HRS, HRS and Extended HRS (ExtHRS). Detailed description Operating…
SOPHIA Genetics
Next Generation Sequencing (NGS)

Homologous Recombination Deficiency (HRD) Solution

Homologous Recombination Deficiency (HRD) Solution NGS- and low-pass whole-genome sequencing (low-pass WGS)-based solution for determining homologous recombination deficiency (HRD) status in ovarian cancer. Operating Principle This comprehensive solution, available as CE-IVD and for Research Use Only (RUO), is designed to support the determination of tumour HRD status in patients with ovarian cancer. It integrates two…
SOPHIA Genetics
Next Generation Sequencing (NGS)